Effective treatment of severe pregnancy and lactation-related osteoporosis with teriparatide: Case report and review of the literature

Polat S. B., Evranos B., Aydın C., Cuhaci N., Ersoy R., Cakir B.

Gynecological Endocrinology, vol.31, no.7, pp.522-525, 2015 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Review
  • Volume: 31 Issue: 7
  • Publication Date: 2015
  • Doi Number: 10.3109/09513590.2015.1014787
  • Journal Name: Gynecological Endocrinology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.522-525
  • Keywords: Fracture, lactation, osteoporosis, pregnancy, teriparatide
  • Ankara Yıldırım Beyazıt University Affiliated: Yes


© 2015 Informa UK Ltd. All rights reserved: reproduction in whole or part not permitted.Pregnancy or lactation-related osteoporosis (PLO) is a very rare and debilitating condition which is usually diagnosed during the last trimester of the pregnancy or early postpartum period. Herein, we report a case with severe PLO and multiple vertebral compression fractures that were successfully treated with teriparatide. Twenty-three-year-old female patient was admitted to our clinic two months after her first spontaneous vaginal delivery with the complaint of severe back pain. Bone mineral density was measured using dual energy X-ray absorptiometry (DEXA), and low T- and Z-scores were observed in lumbar vertebras. In vertebral MRI, severe height loss was detected in thoracic (T) 5,7,10,11,12 vertebras. After exclusion of the other possible causes of OP, she was diagnosed to have PLO and the lactation was stopped. She was treated with calcium 1000 mg/day, cholecalciferol 800 mg/day and teriparatide 20 g/day. At the 12th and 18th month of therapy, BMD was increased by 8% and 27%, respectively, at the lumbar spine and pain was completely relieved in few months. There are pharmacological therapy modalities that can be used in PLO. Bisphosphonates are effective, but there are some concerns that they accumulate in bone and may expose fetus in subsequent pregnancies. Teriparatide is a strong candidate to be the optimal medical therapy in severe cases since it is effective and safe.